Merck announces appointment of Organon & Co. CFO and CIO
KENILWORTH, N.J. — Merck, known as MSD outside the United States and Canada, announced the appointment of Matthew Walsh and Rachel Stahler as chief financial officer and chief information officer, respectively, for Organon & Co., its intended spinoff of its women’s health, legacy brands and biosimilars businesses. In his new role at Organon, Walsh will
